0001567619-20-008133.txt : 20200417 0001567619-20-008133.hdr.sgml : 20200417 20200417172423 ACCESSION NUMBER: 0001567619-20-008133 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200417 DATE AS OF CHANGE: 20200417 EFFECTIVENESS DATE: 20200417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Strella Biotechnology, Inc. CENTRAL INDEX KEY: 0001810011 IRS NUMBER: 842608365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-365337 FILM NUMBER: 20800636 BUSINESS ADDRESS: STREET 1: 3401 GRAYS FERRY AVENUE CITY: PHILADELPHIA STATE: PA ZIP: 19146 BUSINESS PHONE: 703-909-4543 MAIL ADDRESS: STREET 1: 3401 GRAYS FERRY AVENUE CITY: PHILADELPHIA STATE: PA ZIP: 19146 D 1 primary_doc.xml X0708 D LIVE 0001810011 Strella Biotechnology, Inc. 3401 GRAYS FERRY AVENUE PHILADELPHIA PA PENNSYLVANIA 19146 703-909-4543 DELAWARE None None Corporation true 2019 Katherine Sizov c/o Strella Biotechnology, Inc. 3401 Grays Ferry Avenue Philadelphia PA PENNSYLVANIA 19146 Executive Officer Director Promoter Ms. Sizov is the Chief Executive Officer, President, Assistant Secretary and Assistant Treasurer of the Issuer. Jacob Jordan c/o Strella Biotechnology, Inc. 3401 Grays Ferry Avenue Philadelphia PA PENNSYLVANIA 19146 Executive Officer Director Promoter Mr. Jordan is the Chief Operating Officer, Secretary and Treasurer of the Issuer. Brett Topche c/o Strella Biotechnology, Inc. 3401 Grays Ferry Avenue Philadelphia PA PENNSYLVANIA 19146 Director Biotechnology Decline to Disclose 06b false 2020-04-02 false true true Series Seed Preferred Stock. false 0 3316213 3316213 0 false 17 0 0 0 false Strella Biotechnology, Inc. /s/ Katherine Sizov Katherine Sizov President of the Issuer 2020-04-17